Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Volcano Takes Advantage Of Competitors' Trials To Tout FFR, IVUS

This article was originally published in The Gray Sheet

Executive Summary

Intravascular imaging device-maker Volcano is talking up the results of two trials presented at the TCT conference, although it was not the primary sponsor of either of them

You may also be interested in...



St. Jude Diversifies In Intra-Coronary Assessment Market With $90 Mil. Buy

St. Jude Medical is upping the ante in the coronary lesion assessment space with the $90 million cash acquisition of LightLab Imaging

St. Jude Diversifies In Intra-Coronary Assessment Market With $90 Mil. Buy

St. Jude Medical is upping the ante in the coronary lesion assessment space with the $90 million cash acquisition of LightLab Imaging

Lift-Off Time For LipiScan? Data And Payment Policies Will Tell

InfraReDx is in the final planning stages for its first randomized trial to secure a place for its LipiScan intracoronary imaging device in clinical practice

Related Content

Topics

UsernamePublicRestriction

Register

OM013133

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel